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Abstract
To successfully assemble a bio-engineered ovary, we need to create a three-dimensional
matrix able to accommodate isolated follicles and cells. The goal of this study was to
develop an extracellular matrix hydrogel (oECM) derived from decellularized bovine
ovaries able to support, in combination with alginate, human ovarian follicle survival and
growth in vitro. Two different hydrogels (oECM1, oECM2) were produced and compared
in terms of decellularization efficiency (dsDNA), ECM preservation (collagen and glycos-
aminoglycan levels), ultrastructure, rigidity, and cytotoxicity. oECM2 showed significantly
less dsDNA, greater retention of glycosaminoglycans and better rigidity than oECM1.
Isolated human ovarian follicles were then encapsulated in four selected hydrogel
combinations: (1) 100% oECM2, (2) 90% oECM2 + 10% alginate, (3) 75% oECM2 +
25% alginate, and (4) 100% alginate. After 1 week of in vitro culture, follicle recovery
rate, viability, and growth were analyzed. On day 7 of in vitro culture, follicle recovery
rates were 0%, 23%, 65%, 82% in groups 1–4, respectively, rising proportionally with
increased alginate content. However, there was no difference in follicle viability or
growth between groups 2 and 3 and controls (group 4). In conclusion, since pure alginate
cannot be used to graft preantral follicles due to its poor revascularization and degrada-
tion after grafting, oECM2 hydrogel combined with alginate may provide a new and
promising alternative to graft isolated human follicles in a bio-engineered ovary.
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1 | INTRODUCTION
In some cancers grafting of frozen/thawed ovarian tissue cannot be
performed due to the risk of reintroducing malignant cells.1,2 An
alternative to restore fertility in these patients is development of a
transplantable engineered ovary (TEO).3-5 It consists of isolated ovar-
ian follicles, the morpho-functional units of the ovary, which are co-
encapsulated with isolated ovarian cells in a three-dimensional
(3D) scaffold, essential to providing a bio-engineered environment
where follicles can be supported, grow, and interact with ovarian
cells.6
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Encouraging results with mouse follicles have been obtained in vitro
and in vivo with alginate scaffolds.7,8 While alginate has several advantages
for follicle encapsulation, one of the main limitations is its biological inert-
ness, which has hampered its use in in vivo applications due to poor cell
adhesion, limited degradation and revascularization after transplantation.8
To circumvent this problem, previous studies with mouse follicles aimed to
combine alginate with other natural polymers.9-12 Despite their promising
results, alginate-based hydrogels still lack many bioactive factors present in
the ovarian extracellular matrix (ECM).13 To develop a 3D scaffold as simi-
lar as possible to the native organ, hydrogels from decellularized ECM have
been proposed. Decellularization of mammalian tissues aims to remove
antigenic components, while maintaining the biochemical composition of
native ECM. Decellularized tissues can be comminuted to form ECM pow-
ders that, once digested and solubilized into constituent protein mono-
mers, can be further pH- and temperature-neutralized to induce
spontaneous reformation into a hydrogel. ECM hydrogels are collagen-
based and enriched with native sulphated glycosaminoglycans (GAGs), pro-
teoglycans, and ECM proteins.14 When processed appropriately, ECM
hydrogels retain the inherent bioactive features of native ECM, including
peptide domains, which play a major role in integrin-cell attachment, cell
survival, proliferation, and deposition of de novo ECM components. More-
over, they can be easily administered in a minimally invasive manner. The
thermoresponsive nature of ECM hydrogels allows injection of liquid-like,
solubilized ECM that will form a scaffold at physiological body tempera-
tures.14 However, one of the limitations of pure ECM-derived hydrogels is
their low mechanical properties and rigidity which has led to combinations
with other polymers.15 Tissue-derived ECM hydrogels have already dem-
onstrated their potential in a variety of different tissues and organs,
including heart,16,17 brain,18,19 bone,20-22 skin,23 intestine,24 liver,25
kidney,26 meniscus,27 and spinal cord.21
Since each ECM is unique in its topological, mechanical, and
biochemical profile, one of the major challenges in developing ECM-
derived hydrogels is tailoring tissue-specific decellularization protocols
able to preserve the biochemical and physical characteristics of native
ECM. Xenogeneic ECM-derived scaffolds are already being tested in
increasing numbers of preclinical trials,28 and no cases of zoonosis have
been reported to date.14 Moreover, better outcomes were achieved in
terms of efficacy and reproducibility when animal-derived ECMs were
compared with human-derived ECM.29 Importantly, the feasibility and
safety of animal-derived ECM hydrogels have recently been documented
in human clinical trials.30 These important studies open up the possibility
of using animal-derived ECM hydrogels in many other applications.
The goal of this pilot study was to develop and characterize a hydro-
gel derived from decellularized bovine ovarian extracellular matrix (oECM)
to support survival and development of isolated human follicles when it
was combined with alginate. Bovine ovaries were chosen due to their simi-
larity to human ovaries in terms of ultrastructure, follicle dynamics, rigidity,
ECM organization, and composition31-36 and unlimited supply, since they
are normally discarded. Furthermore, some bovine-ECM products have
already been commercialized28 and reportedly used without any safety
issues which is promising for extending possible clinical applications.
In this work, two different decellularization protocols were tested in
order to assess their impact on the hydrogel properties and ECM
preservation: the first protocol had a prolonged enzymatic treatment, and
the second had a short enzymatic treatment in combination with deter-
gents. As bovine ECM-derived hydrogels (oECM) have not previously
been used to encapsulate isolated ovarian preantral follicles, we first eval-
uated hydrogel impact on mouse and human follicle viability. Then to
obtain mechanical properties closer to the human ovary, the selected
oECM hydrogel was combined with alginate to increase its stiffness.
2 | MATERIALS AND METHODS
2.1 | Ethics
The Institutional Review Board of the Université Catholique de Lou-
vain approved the use of human ovarian tissue to isolate preantral
ovarian follicles for this study (reference 2012/23 mar/125). Guide-
lines for animal welfare were approved by the Committee on Animal
Research of the Université Catholique de Louvain on June 29, 2016
(reference 2014/UCL/MD/007).
2.2 | Chemicals and reagents
All reagents were purchased from Sigma-Aldrich (Bornem, Belgium)
unless otherwise stated.
2.3 | Bovine ovary-based ECM hydrogel (oECM)
Bovine ovaries (n = 2) were obtained from young animals (aged 8–
10 years old) from a local slaughterhouse (Abattoir d'Anderlecht,
Brussels, Belgium), transported in Dulbecco's phosphate-buffered
saline (DPBS) at 4C, and processed within 1 h. A longitudinal inci-
sion was made to remove the medulla, all the antral follicles were
aspirated, and corpora lutea were removed. The tissue was cut
into 1 cm2 fragments, plunged into liquid nitrogen for immediate
freezing, and stored at 80C until further use. The choice of
decellularization protocol depends on tissue-specific factors,
including cellularity and density, with most protocols utilizing
chemical, physical or enzymatic agents.37 In this study, ovaries
were decellularised using enzymatic agents alone (protocol 1) or
with detergents (protocol 2) (Figure 1).
2.3.1 | Decellularization of ovarian tissue: protocol
1 (enzymatic)
Thawed ovarian fragments were washed thoroughly in deionized
water and incubated in a 0.05% trypsin-0.02% EDTA solution for 24 h
at 37C and shaken at 300 rpm. The following day, the fragments
were washed in DPBS (1) and then incubated in DPBS for 24 h at
room temperature (RT) under agitation. After a final wash in deionized
water, decellularized ovarian fragments were freeze-dried.
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2.3.2 | Decellularization of ovarian tissue: protocol
2 (enzymatic + detergents)
Thawed ovarian fragments were washed thoroughly in deionized
water and incubated in a 0.05% trypsin-0.02% EDTA solution for 1 h
at 37C and shaken at 300 rpm. The material was then washed in
deionized water, incubated in 3% Triton X-100 for 1 h at RT agitated,
washed again in deionized water, and incubated in 4% sodium
deoxycholate under agitation for 1 h at RT. After a final wash with
deionized water, the tissue was stored in water overnight at 4C and
then incubated in 4% ethanol and 0.2% peracetic acid for 2 h at RT
under agitation before being washed thoroughly in DPBS and then
deionized water before freeze-drying.
2.3.3 | ECM digestion and solubilization
Pepsin digestion and solubilization were carried out to obtain pre-gel
solutions.14 Briefly, lyophilized ECM was added to 1 mg/mL of pepsin
in 0.01 N hydrochloric acid (HCl) for a final concentration of 10 mg
ECM/ml. The suspension was stirred at RT for 72 h. The resulting
pepsin digests were aliquoted and stored at 20C. Gelation of pep-
sin digests was induced by neutralization of salt concentrations and
pH at 4C, followed by warming to 37C. Pre-gel solutions of 8 mg/mL
were prepared and incubated for 1 h at 37C to obtain solid hydrogels
according to each protocol, designated as oECM1 and oECM2.
2.4 | oECM characterization
2.4.1 | DNA, collagen, and sulphated
glycosaminoglycan quantification
More detailed protocols are described in the Supplementary file.
Determination of decellularization efficiency was based on quan-
tification of dry weight double-stranded DNA (dsDNA).21,38 Concen-
trations of dsDNA were measured using a Quant-iT™ Picogreen®
assay kit (Invitrogen, Merelbeeke, Belgium) following the supplier's
instructions.
Since collagen and sulphated GAGs are structural ECM pro-
teins, their content was investigated to determine the rate of
ECM preservation. Collagen content was measured by quantifica-
tion of hydroxyproline.21,39 Briefly, bovine ovarian tissue, oECMs,
and a blank pepsin solution were treated in the same way The
hydrolyzed blank pepsin solution served as a negative control as
well as a diluent for the assay. A standard curve was prepared
using known concentrations of hydroxyproline, ranging from 0 to
100 μg/mL, and absorbance was measured at 540 nm with a
Tecan Infinite M200 pLate reader. Sulphated GAGs were deter-
mined using the 1,9 dimethyl-methylene blue (DMMB) assay,21,40
while a blank pepsin solution served as a negative control as well
as a diluent for the assay. A total of 50 μL of samples were mixed
with 200 μl of DMMB solution (0.03 M sodium formate, 0.046 M
DMMB, ethanol [0.5% v/v] and formic acid [0.2% v/v] in a
96-well plate. The standard curve ranged from 0 to 75 μg/mL
chondroitin-4-sulphate. Absorbance was measured immediately
at 525 nm.
2.4.2 | Mechanical properties of oECM hydrogel
Rheological and gelation characteristics of oECM1 and oECM2 were
determined as previously described20 using a Malvern Kinexus ultra+
rheometer (Malvern Kinexus Pro rotational rheometer and rSpace
software, Malvern Instruments, Worcestershire, UK). Data were
recorded every 30 s(n = 3).
2.4.3 | Microstructure of oECM hydrogel
Both oECM1 and oECM2 (300 μL per well) were fixed in 5% glutaral-
dehyde at RT. Samples were dehydrated in a graded series of ethanol
(25–100%), dried using a critical point dryer (Balzers Union, Balzers,
Finland), and sputter-coated with gold using a Cressington 208HR
metalizer (Eloise s.a.r.l., Tremblay, France). Images were acquired using
a JSM-7600F (JEOL, Zaventem, Belgium) scanning electron micro-
scope at a voltage of 15 kV. Bovine ovarian tissue was used as a
control.
F IGURE 1 Development of a decellularized oECM hydrogel Bovine ovaries were mechanically dissociated with scalpel and forceps to obtain
a homogeneous mixture of small ovarian fragments which were then treated with enzyme and/or detergents, lyophilized and pepsin digested to
obtain a hydrogel for follicle encapsulation and in vitro culture
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2.5 | Isolation and viability of preantral follicles
2.5.1 | Isolation and viability of mouse preantral
follicles
All procedures were carried out under a laminar flow hood using ster-
ilized materials. The ovaries of four severe combined immunodeficient
(SCID) mice (5 weeks of age) were removed, as already reported,5 and
follicles were isolated according to our routine procedure.41 To assess
the impact of the follicle isolation procedure, follicle viability was eval-
uated soon after isolation using a vital assay (Invitrogen), as previously
described.42 Follicles were classified into four categories43 based on
oocyte and granulosa cell viability: V1 and V2 represented follicles
with high viability (0% and <10% dead granulosa cells, respectively)
and V3 and V4, follicles with poor viability (≥10% and >50% dead
granulosa cells or a dead oocyte). Before encapsulation, follicles were
first washed and then embedded into oECM1 and oECM2.
2.5.2 | Isolation and viability of human preantral
follicles
Frozen ovarian tissue samples from three patients of reproductive age
with non-ovarian pathologies were taken from the ovarian tissue
bank, after obtaining written informed consent. Tissues were
thawed44 and follicles isolated.45 Follicle viability was calculated as
described above (see section 2.5.1).
2.6 | Ovarian follicle encapsulation
2.6.1 | Mouse ovarian follicle encapsulation
Mouse ovarian follicles were encapsulated only in oECM1 and oECM2
to evaluate the cytotoxicity of the ovarian ECM hydrogels and avoid
any waste of precious human follicles.
Firstly 339 follicles were divided into two groups (oECM1 and
oECM2), and their diameter was recorded before being encapsulated
separately in each group. Between 10 and 15 follicles were embedded
in 50 μL oECM1 (8 mg/mL) or oECM2 (8 mg/mL), placed in a 4-well
plate and incubated at 37C for 1 h to allow gelation (oECM1 n = 20
beads, oECM2 n = 3 beads). Thereafter, 500 μL pre-equilibrated
in vitro culture medium (MEM, GlutaMAX, Gibco, Merelbeeke,
Belgium) supplemented with 10% fetal bovine serum (Gibco),
2 mM pyruvic acid 50 μg/mL ascorbic acid, 0.1 IU/mL follicle stim-
ulating hormone (FSH) (Gonal F, Merck, Darmstadt, Germany), 1%
Antibiotic-Antimycotic (Anti-Anti; Gibco) were added. The hydro-
gels were cultured at 37C and 5% CO2 for 1 week. Every 2 days,
half of the culture medium was removed and replaced with fresh
medium.
2.6.2 | Human ovarian follicle encapsulation
A more detailed protocol is described in the Supplementary file.
Isolated primordial and primary follicles (n = 114) were divided
into 4 groups and their diameter was recorded before being encapsu-
lated in: (1) 100% oECM2 (8 mg/mL); (2) 90% oECM2 + 10% of 1%
alginate (SLM100; Pronova, Nova Matrix, Sandvika, Norway); (3) 75%
oECM2 + 25% of 1% alginate; or (4) 100% of 1% alginate.42 Incuba-
tion at 37C for 1 h was performed to allow oECM2 to gel, which was
then followed by addition of 100 μL CaCl2 100 mM for a few seconds
to induce alginate cross-linking. A 100 μl of culture medium was then
added to each well and the samples were stored at 37C and 5% CO2
for 1 week. Every 2 days, half of the culture medium was removed
and replaced with fresh medium.
2.7 | Follicle recovery rate, viability, and in vitro
growth
Follicle recovery rates, viability and growth were evaluated after
7 days of in vitro culture. On day 7, the follicle recovery rate was cal-
culated for each bead and then compared (mean ± SD) for each group
as follow:
Number of recovered follicles¼ FE=FFð Þ*100
where FE is the encapsulated follicles on day 0; FF is the follicles found
on day 7.
F IGURE 2 Influence of the ovarian decellularization protocol on dsDNA, collagen and GAG content Efficiency of decellularization was
assessed by quantifying level of dry weight dsDNA/mg (A). Preservation of the ECM after decellularization was assessed by quantifying collagen
(B) sulphated GAG (C) and rheological properties (D) through investigation of storage (G0) and loss moduli (G00) Data are presented as mean ± SD.
Significant differences are represented by asterisks. (** p < .01; ****p- < .0001). Each group was analysed in triplicate
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In order to measure follicle viability, vital assays were conducted
as previously documented (see section 2.5.1).
Follicle growth was evaluated by measuring follicle diameters
under an inverted microscope, using a scale incorporated in the objec-
tive lens at 10 magnification. On days 0 and 7 of in vitro culture,
each follicle was measured and the mean ± SD was compared
between these time points for each group.
2.8 | Statistical analysis
Statistical analyses were performed with Prism 8.1.2.
Detailed methods are described in the Supplementary file. This
research has benefited greatly from statistical consultation with the
Statistical Methodology and Computing Service technological plat-
form at the UCL (SMCS/IMMAQ, UCL).
3 | RESULTS
3.1 | Decellularization impacted residual DNA and
GAGs content, but not collagen proportions in oECM
hydrogels
oECM1 and oECM2 dsDNA, collagen and GAGs content was quanti-
fied and compared to native bovine ovarian tissue. The concentration
of nucleic acid (mean ± SD) was significantly higher (p < .0001) in
native tissue (1750-fold) than in oECM1 or in oECM2 (Figure 2A).
TABLE 1 Storage and loss modulus (mean ± SD) in oECM1 and
oECM2 hydrogels
oECM1 (n = 3) oECM2 (n = 3)
Storage modulus (G0) 65 ± 18 Paa 107 ± 27 Pab
Loss modulus (G00) 9.5 ± 2 Paa 7 ± 1.7 Pab
Note: Different superscript letters indicate statistical differences
(a, b, p < .05).
Abbreviations: oECM1, ovarian-derived extracellular matrix hygdogel 1.
oECM2, ovarian-derived extracellular matrix hygdogel 2.
F IGURE 3 Influence of decellularization on oECM hydrogel microstructure Native bovine ovarian tissue (A), oECM1 (B) and oECM
2 (C) hydrogels were processed for scanning electron microscopy. Magnification: 12,000; scale bar: 1 μm
F IGURE 4 Influence of oECM
hydrogel on mouse ovarian follicle
morphology Isolated mouse preantral
follicles (from primordial-to secondary
follicle stage) before encapsulation in
oECM1 (A) and oECM2 (B) hydrogels. No
difference in follicle morphology was
found (A, B) before in vitro culture. Mouse
follicles in oECM1 on day 7 of in vitro
culture (C), mouse follicles in oECM2 on
day 7 of in vitro culture (D). Black arrow
indicates encapsulated ovarian follicles
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When comparing oECM1 and oECM2, a significantly(p < .0001) higher
concentration of dsDNA was found in the oECM1 hydrogel.
No difference in collagen content was observed between native
tissue (n = 2, 0.67 ± 0.3 mg/mg of dry weight), oECM1 (n = 3, 0.89
± 0.06 mg/mg of dry weight) or oECM2 (n = 3, 0.67 ± 0.2 mg/mg of
dry weight) (Figure 2B). sGAG content was significantly higher
(p < .01) in oECM2 (2.7-fold) compared to oECM1 and equivalent to
native tissue (Figure 2C).
3.2 | Decellularization influenced oECM hydrogel
mechanical properties
Storage modulus (G0) and the loss modulus (G00) represent the
mechanical strength and the viscous portion of hydrogel, respec-
tively. G0 and G00 of pre-gel solutions increased after 5 min after pH
neutralization and temperature elevation (Figure 2D), indicating the
beginning of the gelation process that plateaued after 8 min. G0 was
always higher than G00 in both hydrogels. Irrespective of the
decellularization protocol, gelation kinetics were similar, even though
the final moduli were statistically different (Table 1). Indeed, oECM2
showed a G0 value superior (p < .05) to the oECM1 hydrogel modu-
lus, while oECM1 hydrogel G00 was significantly higher (p < .0001)
than the oECM2 hydrogel.
3.3 | Influence of decellularization on oECM
hydrogel microstructure
Bovine ovarian tissue was structurally heterogeneous. Dense and
compact regions alternated with fibrous regions showing fibers of var-
iable thickness. The porosity of the bovine ovarian ECM appeared to
correlate inversely with the degree of crosslinking of tissue fibers.
Regions with thicker tissue fibers and apparently inferior porosity
alternated with regions of thinner fibers and greater porosity
(Figure 3A). Decellularization of oECM hydrogels strongly influenced
their morphology (Figure 3). While the oECM1 hydrogel had a highly
porous and fibrillary structure with small and homogeneous fibers
(Figure 3B), oECM2 hydrogel displayed a sponge-like structure with
thicker walls and heterogeneous pores (Figure 3C).
3.4 | Impact of decellularization on follicle
recovery, viability, and growth
3.4.1 | Mouse follicle recovery rate, viability and
growth
A total of 339 mouse follicles were isolated under the stereomicro-
scope. Before follicle encapsulation and in vitro culture, 50 follicles
were investigated for follicle viability. Percentages (n = 50 follicles) of
fully viable (V1) and minimally damaged (V2) follicles were 22% and
TABLE 2 Mouse ovarian follicle diameter (mean ± SD) in oECM1
and oECM2 on day 0 and day 7 of in vitro culture
Mouse follicle diameter (mean ± SD)
oECM1 oECM2
Day 0 45 ± 22 μma
(n = 235)
51 ± 27.5 μma
(n = 54)
Day 7 43 ± 21 μma
(n = 174)
65 ± 34 μma
(n = 12)
Note: Different superscript letters indicate statistical differences
(a, b, p < .05).
Abbreviations: oECM1, ovarian-derived extracellular matrix hygdogel 1.
oECM2, ovarian-derived extracellular matrix hygdogel 2.
F IGURE 5 Influence of oECM2- hydrogel combinations on human ovarian follicle morphology. Group 2 represents 90% oECM2 + 10%
alginate bead (A), Group 3 represents 75% oECM2 + 25% alginate bead (B), Group 4 represents 100% alginate bead. Black arrows indicate the
presence of human follicles on day 7 of in vitro culture (A–C). When alginate was combined to oECM2, the hydrogel bead appeared more
transparent and homogeneus in a dose dependent manner after 7 days of in vitro culture
TABLE 3 Human ovarian follicle viability (mean ± SD) in
oECM2-based hydrogels on day 7 of in vitro culture
Human ovarian follicle viability (V1 + V2)
Group 1 Group 2 Group 3 Group 4
*ND 87.5%a 97.2%a 87.5%a
Note: Different superscript letters indicate statistical differences
(a,b, p < .05). Group 1:100% oECM2 hydrogel. Group 2:90% oECM2
hydrogel +10% alginate. Group 3:75% oECM2 hydrogel +25% alginate.
Group 4:100% alginate.
*ND: no follicles were found in oECM2 on day 7.
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52%, respectively, while highly damaged (V3) or dead (V4) follicles
represented 10% and 16%, respectively. Hence, 74% of follicles were
viable soon after isolation from mouse ovaries.
After encapsulation in oECM hydrogels and 1 week of culture,
the follicle morphology was similar between oECM1 and oECM2
(Figure 4). Follicle recovery rates (54 ± 27% oECM1 [n = 20 beads],
47.5 ± 39% oECM2 [n = 3 beads]) and viability (V1 + V2, 69.5% and
50%) were not statistically different. Regarding follicle diameter, no
statistical difference was observed regardless of oECM hydrogels
used between day 0 and day 7 (Table 2).
3.4.2 | Human follicle recovery rate, viability, and
growth
For experiments with human follicles, only oECM2 was selected,
based on its lower dsDNA content, higher GAG content and higher
storage modulus. A total of 127 human follicles were identified under
the stereomicroscope. Percentages of fully viable (V1) and minimally
damaged (V2) follicles were 61% and 31%, respectively, which means
that 92% of isolated follicles were viable before follicle encapsulation.
No highly damaged (V3) and very few dead (V4) follicles (8%) were
counted before follicle encapsulation.
On day 7, follicle morphology was similar between all groups but
one (group 1, no follicle found) (Figure 5). Follicle recovery rates
increased proportionally with the percentage of alginate added to
oECM2: 0%, 23%, 65%, and 85% from group 1 to group 4, respec-
tively. No follicles were recovered in group 1, but granulosa cells were
attached and spread all over the hydrogel beads. After 1 week of cul-
ture in the different hydrogels, no difference was observed in follicle
viability (Table 3) in any but one (group 1). Additionally, follicle diame-
ter was similarly and significantly increased in any but one (group 1)
(Table 4).
4 | DISCUSSION
In this study, two different ECM-derived hydrogels were produced
from bovine ovaries. When decellularization efficiency was investi-
gated, both hydrogels showed a drastic reduction in dsDNA compared
to native tissue. According to Crapo et al.37 decellularized hydrogels
should possess less than 50 ng dsDNA per mg of initial dry weight of
decellularized ECM to limit the presence of residual antigenic material,
which may induce an immune response in vivo. Although both hydro-
gels contained less than 50 ng/mg dsDNA, a significantly greater
reduction in dsDNA (>99%) was obtained with the second protocol
(oECM2) compared to native tissue. One of the main reasons for this
difference is likely the addition of ionic (Triton X-100) and non-ionic
(sodium deoxycholate) detergents to the second decellularization pro-
tocol. Indeed, Triton X-100 is known to disrupt DNA-protein interac-
tions, and sodium deoxycholate to efficiently disrupt cell nuclei and
membranes.46 Compared to other protocols for decellularization of
mouse, bovine, porcine and even human ovaries,4,34,47-50 we achieved
a greater reduction in initial dsDNA without using DNase, which has
been shown to induce cytotoxicity of reseeded cells.51
Quantification of collagen and GAGs, major structural components
of the ECM, provided assessment of ECM preservation in our oECM
hydrogels. Similarly to other studies,4,48 we did not observe any differ-
ence in collagen content between native tissue and either of the two
hydrogels. However, only protocol oECM2 allowed preservation of sim-
ilar levels of GAGs to native tissue. GAGs are heteropolysaccharides,
not only involved in ECM structure, but also in water retention and
growth factor sequestering. GAGs can thereby promote cell adhesion,
growth, differentiation and migration.52 A recent proteomic study on
human ovarian tissue demonstrated that GAGs are widely distributed
throughout human ovarian cortex, making them key components of the
native ovarian ECM.53 Several authors have also shown that GAGs are
directly or indirectly involved in follicle development, granulosa cell dif-
ferentiation, and cumulus-oocyte expansion.54,55 Hence an enriched
GAG hydrogel, such as oECM2 may better support human follicle sur-
vival in vitro than oECM1.
Physical scaffold properties, such as hydrogel rigidity and nano-
structure, are other essential parameter for the creation of a TEO.35,56
As expected, both oECM1 and oECM2 exhibited a lower storage
modulus than native ovarian tissue (~3.5 KPa),33,57 but more interest-
ingly, they differed significantly from each other, with oECM2 being
more rigid than oECM1. Because both hydrogels were derived from
the same tissue source, with equal concentration and similar collagen
content, the difference in stiffness is likely due to either the higher
numbers of sulphated GAG retained in oECM2 and/or different ultra-
structure observed by scanning electron microscopy. Structurally,
oECM2 exhibited a less fibrous architecture with thicker and more
TABLE 4 Human ovarian follicle
diameter (mean ± SD) in boECM2-based
hydrogels on day 0 and day 7 in vitro
culture
Human follicle diameter (mean ± SD)
Group 1 Group 2 Group 3 Group 4
Day 0 33 ± 20 μma (n = 12) 38 ± 12 μma
(n = 15)
43 ± 12 μma
(n = 22)
38 ± 12 μma (n = 20)
Day 7 *ND
(n = 0)
59 ± 24 μmb
(n = 8)
58 ± 24 μmb
(n = 12)
58 ± 19 μmb
(n = 17)
Note: Different superscript letters indicate statistical differences (a,b p < .05). Group 1:100% oECM2
hydrogel. Group 2:90% oECM2 hydrogel +10% alginate. Group 3:75% oECM2 hydrogel +25% alginate.
Group 4:100% alginate.
*ND: no follicles were found in oECM2 on day 7.
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compact walls than oECM1, which may reflect a distinct collagen
fiber reorganization during gelation and hence a different degree of
rigidity.58 It could also be the result of the shorter enzymatic decellu-
larization process in the second protocol, which in turn better
preserves GAG concentration and generated larger fibers.14
Although the ultrastructure of oECM1 might appear more similar
than oECM2 to the human ovary,35 additional investigations are nec-
essary before uttering any conclusions. Since all the other parameters
of oECM1 (DNA content, GAGs, and storage modulus) were statisti-
cally inferior to oECM2, given a possible clinical application, a safer
biomaterial with inferior cellular debris, like oECM2, is the first choice.
To assess hydrogel cytocompatibility, isolated mouse preantral folli-
cles were initially used in order to safeguard precious human follicles.
No statistical differences were found in follicle recovery rates or via-
bility between oECM1 and oECM2 after 1 week of in vitro culture, so
both hydrogels were equally able to support mouse follicle survival
in vitro. However, since the aim of this study was to create a support-
ive scaffold for human ovarian follicles, it is important to bear in mind
that the follicle requirements of a TEO are species-specific and differ
substantially between rodents and humans.59,60 Therefore, based on
the lower dsDNA content, greater GAG retention, and superior stiff-
ness, which are all favorable conditions to better support human folli-
cle survival,35,61 we selected oECM2 as a promising new scaffold
material for the TEO, using it to encapsulate and culture human folli-
cles. In contrast to what we observed with fresh mouse follicles, no
human follicles were found in the oECM2 alone after 1 week of
in vitro culture. However, fully viable and elongated granulosa cells
(as evidenced by live/dead assay) were present throughout this hydro-
gel. These different findings may be due to suboptimal in vitro culture
conditions for isolated human primordial/primary follicles62 and the
cryopreservation procedure applied to human ovarian tissue. Indeed,
Wang et al.63 demonstrated that freshly isolated human ovarian folli-
cles were less impaired in terms of viability and growth than vitrified
and slow-frozen counterparts after 8 days of in vitro culture. Addi-
tionally, this difference may also highlight that mouse and human folli-
cles require different environments and that decellularized ovarian
ECM hydrogels may not be able to uniformly support species-
independent follicle survival and growth.
Considering the impact of matrix rigidity on human follicle
survival,35,61 and because the oECM2 modulus was lower than in
native ovary,33,57 we decided to increase the mechanical properties of
the ECM hydrogel by adding alginate. As expected, when alginate was
combined with oECM2, the follicle recovery rates increased propor-
tionally, up to a maximum achieved with alginate alone. In 7-day cul-
tures of oECM2 alone, human follicles lost their spherical shape, and
granulosa cells spread throughout the hydrogel and proliferated. It is
therefore likely that oECM2 alone was not rigid enough to maintain
the 3D structure of isolated human follicles, but it was not toxic and
so was able to support cell attachment and proliferation. While algi-
nate alone was superior in terms of follicle recovery rate to other
hydrogels combinations, it is unfortunately unsuitable alone for possi-
ble future clinical application in the TEO due to its low degradability
and poor revascularization after transplantation.41,64 However, given
that no differences were observed between human ovarian follicle
viability and growth in alginate and oECM2-alginate combinations, the
addition of alginate to oECM2 may well improve scaffold rigidity. The
hypothesis that scaffold rigidity may influence follicle survival has
already been posited.35,61,65-67 Hornick et al.65 showed that when iso-
lated nonhuman primate preantral follicles were cultured in 0.5% (soft)
and 2% (stiff) alginate, follicles maintained their spherical structure
and survived only in the stiffer alginate (2%). Additionally, Lambricht
et al.68 characterized the chemical and physical properties of different
hydrogels and demonstrated that SLM 100 alginate (1%) exhibited
rigidity (~4 KPa) similar to bovine and human ovarian tissue.
Although no other studies to date have reported on ovarian
ECM-derived hydrogels, Pors et al.4 recently obtained encouraging
findings with isolated human ovarian follicles cultured in a dec-
ellularized human ovarian ECM scaffold. Unlike our study, human
ovarian follicles were first wrapped between two sheets of previously
cultured ovarian cells and only then placed together inside the dec-
ellularized ovarian scaffold.4 Hence, the presence of ovarian stromal
cells, essential for appropriate bidirectional communication with folli-
cles, as well as secreted autologous ovarian cell-derived ECM, may
have contributed to follicle survival. Therefore, in order to support
longer human follicle survival in vitro, the addition of ovarian cells
should be considered in future studies.
We are aware that this is a pilot study, and it has therefore sev-
eral limitations, such as the lack of some critical functional assays and
longer periods of in vitro culture. Moreover, further in vivo investiga-
tions (e.g., xenografting model) are required to confirm the hydrogel
potential for supporting human folliculogenesis and assessing its deg-
radation and vascularization. Finally, some tests with immunocompe-
tent animal models should be performed to evaluate the host
immunogenic response to the hydrogel.
It is equally important to point out that since this is a pilot study,
we decided to use ovaries from only two cows. However, ovaries vary
among animals, considering several aspects, such as the estrous cycle,
animal age, breed, and health status. Hence, to decrease the hydrogel
composition variability, the best option is to pool ovaries from several
animals. This is also necessary because a single ovary would be insuffi-
cient to produce enough ECM-derived hydrogel.
5 | CONCLUSIONS
Both hydrogels were able to support mouse follicle survival in vitro.
However, taking into account that requirements to support follicle
survival in TEO are species-specific, we selected oECM2 as it proved
better than oECM1 to culture human ovarian follicles. Nevertheless,
pure oECM2 was not able to sustain human follicle survival in vitro,
probably due to its relative softness compared to human ovarian tis-
sue. On the other hand, when alginate was combined with oECM2, up
to 65% of fully viable and growing follicles were detected on day 7 of
culture. Since alginate alone is not suitable for TEO clinical translation,
combined oECM2-alginate hydrogels may offer an innovative strat-
egy. We hope that this derived oECM hydrogel may function as a
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biomimetic environment, with retention of ovarian ECM proteins
essential for proper follicle development, greater degradability, and
enhanced revascularization after grafting.
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